Comparison of Conventionally Manufactured AFO and Modular Customized AFO (AFO4-0)
Primary Purpose
Gait, Drop Foot
Status
Recruiting
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Modular customized AFO
Sponsored by
About this trial
This is an interventional screening trial for Gait, Drop Foot
Eligibility Criteria
Inclusion Criteria:
Participants fulfilling all of the following inclusion criteria are eligible for the study:
- Patients (11-18 yrs.), who need a new orthosis (visit to an orthopedic technician)
- Patients (18-65 yrs.), who need a new orthosis (visit to an orthopedic technician)
- Informed Consent provided as documented by signature
- Confirmed diagnosis of cerebral palsy
- Confirmed diagnosis of spastic equinus and/ or drop foot,
- Gait pathologies treated with conventional AFO
- Gross Motor Function Classification System (GMFCS) level I or II
Exclusion Criteria:
- Other neuromuscular diseases
- Surgical intervention lower extremities past 12 months to improve gait pathologies
- Injections of Botulinum toxin 6 months prior to study inclusion
- Inability or unwillingness to follow the procedures of the gait analysis
- in women: pregnancy
Sites / Locations
- University of BaselRecruiting
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Modular customized AFO
Arm Description
Walks better at self selected speed with a modular customized AFO than with a conventional AFO.
Outcomes
Primary Outcome Measures
Gait Profile Score (GPS)
The primary outcome measure is the gait profile score (GPS), which is an overall score calculated from all kinematic parameters (joint rotation angles) of the affected leg and expressed as the deviation from the normal gait cycle in degrees.
The outcome of the GPS will be compared between the conventional AFO, and modular customized AFO for each participant and for each group.
Secondary Outcome Measures
Movement Analysis Profile (MAP) and spatial-temporal parameters
Secondary outcomes are the Movement analysis profile (MAP) and spatial-temporal parameters, both calculated from kinematic parameters and expressed as the deviation from the normal gait cycle in degrees.
The MAP consists of individual scores for each joint rotation angle (pelvic tilt, pelvic obliquity, pelvic rotation, hip flexion/extension, hip abduction/adduction, hip rotation, knee flexion/extension, ankle dorsiflexion/extension and foot progression) of the affected leg [2]. Spatial-temporal parameters are walking speed (m/s), cadence (steps/min x 100) and stride length (m) of the affected leg.
The above-mentioned parameters will be compared between the conventional AFO, and modular customized AFO for each participant and for each group.
Full Information
NCT ID
NCT05192915
First Posted
December 13, 2021
Last Updated
November 1, 2022
Sponsor
Beat Göpfert
Collaborators
Innosuisse - Swiss Innovation Agency
1. Study Identification
Unique Protocol Identification Number
NCT05192915
Brief Title
Comparison of Conventionally Manufactured AFO and Modular Customized AFO
Acronym
AFO4-0
Official Title
Comparison of Conventionally Manufactured Lower Leg Orthoses and Modular Customized Lower Leg Orthoses (AFO 4.0) in Patients With Limited Neuromuscular Foot Function During Overground Walking
Study Type
Interventional
2. Study Status
Record Verification Date
November 2022
Overall Recruitment Status
Recruiting
Study Start Date
February 25, 2022 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
January 31, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Beat Göpfert
Collaborators
Innosuisse - Swiss Innovation Agency
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The Investigator will investigate the difference in the gait pattern between 2 commercially available ankle foot orthoses (AFO): a) conventionally manufactured AFO and b) modular customized AFO using Industry 4.0 technology.
Measurement method: The participants perform an instrumented gait analyses while overground walking at a self - selected speed using a conventionally manufactured AFO or a modular customized AFO.
Detailed Description
Cerebral palsy (CP) is the most common movement disorder in children [Stavsky, 2017]. It is frequently accompanied by spasticity [Baker, 2009]. The typical symptoms of spastic cerebral palsy are gait abnormalities such as equinus and drop foot that lead to severe impairments in daily life [Armand, 2016]. As these symptoms will persist in adulthood, an AFO is frequently required in this patient population.
Furthermore, other neurological diseases e.g stroke [Choo, 2021], spinal cord injury, and peripheral nerve injury may require the daily use of an AFO.
Ankle-foot orthoses (AFO) have been suggested to improve the dynamic efficiency of the gait. In addition, a positive effects on gait kinetics and kinematics have been reported [Figueiredo, 2008].
Recently, modular customized AFO are increasingly proposed as their response can be tuned to the patient's gait characteristics and/or functional maturity [6]. However, the evidence on this topic is still lacking and modular customized AFO are not yet established in clinical routine.
The aim of this study is to assess gait parameters with an instrumented gait analysis of the modular customized AFO compared to conventional, untuned AFO in a group of adolescents and a group of adults using for there daily activity an AFO, while over ground walking at self selected speed over a distance of about 10 m.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gait, Drop Foot
7. Study Design
Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
This study is a prospective, cross-sectional within-subjects comparison
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Modular customized AFO
Arm Type
Other
Arm Description
Walks better at self selected speed with a modular customized AFO than with a conventional AFO.
Intervention Type
Device
Intervention Name(s)
Modular customized AFO
Intervention Description
Walks better at self selected speed with a modular customized AFO than with a conventional AFO.
Primary Outcome Measure Information:
Title
Gait Profile Score (GPS)
Description
The primary outcome measure is the gait profile score (GPS), which is an overall score calculated from all kinematic parameters (joint rotation angles) of the affected leg and expressed as the deviation from the normal gait cycle in degrees.
The outcome of the GPS will be compared between the conventional AFO, and modular customized AFO for each participant and for each group.
Time Frame
immediately after the intervention (gait analysis)
Secondary Outcome Measure Information:
Title
Movement Analysis Profile (MAP) and spatial-temporal parameters
Description
Secondary outcomes are the Movement analysis profile (MAP) and spatial-temporal parameters, both calculated from kinematic parameters and expressed as the deviation from the normal gait cycle in degrees.
The MAP consists of individual scores for each joint rotation angle (pelvic tilt, pelvic obliquity, pelvic rotation, hip flexion/extension, hip abduction/adduction, hip rotation, knee flexion/extension, ankle dorsiflexion/extension and foot progression) of the affected leg [2]. Spatial-temporal parameters are walking speed (m/s), cadence (steps/min x 100) and stride length (m) of the affected leg.
The above-mentioned parameters will be compared between the conventional AFO, and modular customized AFO for each participant and for each group.
Time Frame
immediately after the intervention (gait analysis)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
11 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Participants fulfilling all of the following inclusion criteria are eligible for the study:
Patients (11-18 yrs.), who need a new orthosis (visit to an orthopedic technician)
Patients (18-65 yrs.), who need a new orthosis (visit to an orthopedic technician)
Informed Consent provided as documented by signature
Confirmed diagnosis of cerebral palsy
Confirmed diagnosis of spastic equinus and/ or drop foot,
Gait pathologies treated with conventional AFO
Gross Motor Function Classification System (GMFCS) level I or II
Exclusion Criteria:
Other neuromuscular diseases
Surgical intervention lower extremities past 12 months to improve gait pathologies
Injections of Botulinum toxin 6 months prior to study inclusion
Inability or unwillingness to follow the procedures of the gait analysis
in women: pregnancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Beat Goepfert, MEng, EMBA
Phone
+41 61 207 54 28
Email
Beat.goepfert@unibas.ch
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Beat Goepfert, MEng, EMBA
Organizational Affiliation
University of Basel
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Basel
City
Basel
State/Province
BS
ZIP/Postal Code
4000
Country
Switzerland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Beat Goepfert, MEng, EMBA
Email
beat.goepfert@unibas.ch
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
28243583
Citation
Stavsky M, Mor O, Mastrolia SA, Greenbaum S, Than NG, Erez O. Cerebral Palsy-Trends in Epidemiology and Recent Development in Prenatal Mechanisms of Disease, Treatment, and Prevention. Front Pediatr. 2017 Feb 13;5:21. doi: 10.3389/fped.2017.00021. eCollection 2017.
Results Reference
background
PubMed Identifier
19632117
Citation
Baker R, McGinley JL, Schwartz MH, Beynon S, Rozumalski A, Graham HK, Tirosh O. The gait profile score and movement analysis profile. Gait Posture. 2009 Oct;30(3):265-9. doi: 10.1016/j.gaitpost.2009.05.020. Epub 2009 Jul 24.
Results Reference
background
PubMed Identifier
28698802
Citation
Armand S, Decoulon G, Bonnefoy-Mazure A. Gait analysis in children with cerebral palsy. EFORT Open Rev. 2016 Dec 22;1(12):448-460. doi: 10.1302/2058-5241.1.000052. eCollection 2016 Dec.
Results Reference
background
PubMed Identifier
34354172
Citation
Choo YJ, Chang MC. Effectiveness of an ankle-foot orthosis on walking in patients with stroke: a systematic review and meta-analysis. Sci Rep. 2021 Aug 5;11(1):15879. doi: 10.1038/s41598-021-95449-x.
Results Reference
background
PubMed Identifier
18703958
Citation
Figueiredo EM, Ferreira GB, Maia Moreira RC, Kirkwood RN, Fetters L. Efficacy of ankle-foot orthoses on gait of children with cerebral palsy: systematic review of literature. Pediatr Phys Ther. 2008 Fall;20(3):207-23. doi: 10.1097/PEP.0b013e318181fb34.
Results Reference
background
Learn more about this trial
Comparison of Conventionally Manufactured AFO and Modular Customized AFO
We'll reach out to this number within 24 hrs